A cross-disciplinary team of scientists,... - Wissenschaft und Deutsch
A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.Most therapeutic cancer vaccines available today require doctors to first remove the patient’s immune cells from the body, then reprogram them and reintroduce them back into the body. The new approach, which was first reported to eliminate tumors in mice in Science Translational Medicine in 2009, the year the Wyss Institute was launched, instead uses a small disk-like sponge about the size of a fingernail that is made from FDA-approved polymers. The sponge is implanted under the skin, and is designed to recruit and reprogram a patient’s own immune cells “on site,” instructing them to travel through the body, home in on cancer cells, then kill them.The technology was initially designed to target cancerous melanoma in skin, but might have application to other cancers. In the preclinical study reported in Science Translational Medicine, 50 percent of mice treated with two doses of the vaccine—mice that would have otherwise died from melanoma within about 25 days—showed complete tumor regression.http://medicalxpress.com/news/2013-09-therapeutic-cancer-vaccine-human-clinical.html
sourced from all science, all the time

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

Most therapeutic cancer vaccines available today require doctors to first remove the patient’s immune cells from the body, then reprogram them and reintroduce them back into the body. The new approach, which was first reported to eliminate tumors in mice in Science Translational Medicine in 2009, the year the Wyss Institute was launched, instead uses a small disk-like sponge about the size of a fingernail that is made from FDA-approved polymers. The sponge is implanted under the skin, and is designed to recruit and reprogram a patient’s own immune cells “on site,” instructing them to travel through the body, home in on cancer cells, then kill them.

The technology was initially designed to target cancerous melanoma in skin, but might have application to other cancers. In the preclinical study reported in Science Translational Medicine, 50 percent of mice treated with two doses of the vaccine—mice that would have otherwise died from melanoma within about 25 days—showed complete tumor regression.

http://medicalxpress.com/news/2013-09-therapeutic-cancer-vaccine-human-clinical.html

sourced from all science, all the time

  1. cyrrane reblogged this from scienceyoucanlove
  2. brightstarflower reblogged this from motherfucking-kidneys
  3. motherfucking-kidneys reblogged this from you-aremy-mission
  4. oreo-butt reblogged this from you-aremy-mission
  5. you-aremy-mission reblogged this from somethingnerdythiswaycomes
  6. somethingnerdythiswaycomes reblogged this from subliminaltwist
  7. jkellyx2 reblogged this from commodorecookie
  8. commodorecookie reblogged this from ladylatey
  9. redninja-kun reblogged this from joodster
  10. ladylatey reblogged this from i-juggle-goslings
  11. joodster reblogged this from joannachristie
  12. joannachristie reblogged this from lostbri
  13. lostbri reblogged this from farseerscreed
  14. jagonfly reblogged this from scienceyoucanlove
  15. veroldnyogod reblogged this from scienceyoucanlove
  16. micahaphone reblogged this from scienceyoucanlove
  17. sinnserotonin reblogged this from geekdean
  18. owleyezz reblogged this from heyitsthatguyyouknow
  19. theinterrupted reblogged this from scienceyoucanlove
  20. naturallydisillusioned reblogged this from scienceyoucanlove
  21. moshing-with-kittens reblogged this from badgersliketoast
  22. opheliaticlove reblogged this from shockofthelightning
  23. shockofthelightning reblogged this from bwhoyouwant2be